Most neurodegenerative diseases have animal parallels such as Alzheimer's in chimpanzees, multiple sclerosis in macaques, Lou Gehrig's disease in dogs, but nothing like Parkinson's has ever been seen in any species but humans. Synuclein and the Coelacanth: The Molecular and Evolutionary Origins of Parkinson's Disease delves into the causes of Parkinson's disease and how the evolution of the human brain has left us uniquely vulnerable. Genetic risk factors, environmental toxins, and neuroanatomy are woven together in a multidisciplinary discussion that ranges from subatomic physics to socioeconomics. Connections between neurodegenerative disease, neural pathways, and innate immunity are explored. Finally, the author discusses new therapeutic agents are being developed that hope to go beyond just treating the symptoms of Parkinson's and actually halt the disease.
Sprache
Verlagsort
Verlagsgruppe
Elsevier Science & Technology
Zielgruppe
Für Beruf und Forschung
Primary: Researchers and medical professionals in neuroscience and molecular biology
Secondary: Patients and families interested in learning more about the science of Parkinson's disease
Maße
Höhe: 229 mm
Breite: 152 mm
Gewicht
ISBN-13
978-0-323-85707-9 (9780323857079)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
James M. Gruschus is a molecular biophysicist with a Ph.D. in physics from Cornell University. He is currently employed as a staff scientist in the Laboratory of Structural Biophysics, National Heart, Lung & Blood Institute, National Institutes of Health, Bethesda, MD, and resides in Washington, DC.
Autor*in
Molecular Biophysicist, Staff Scientist, Laboratory of Structural Biophysics, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA
1. Out of the Depths - The synuclein proteins, their evolution, and the genetic code2. Bad News, Good News - The demographics and genetic and environmental risk factors for Parkinson's disease 3. The Family Tremor - REM sleep behaviour disorder and essential tremor 4. The Knockout - The history of the knockout mouse and the surprising results for the synuclein proteins 5. Shapeshifter - The molecular structure and normal biological role of synuclein in neurons 6. A New Kind of Pathogen - Prion diseases and amyloid fibrils 7. Addicts - Neurotoxins that cause parkinsonism and the search for analogues in the environment 8. Attack of the Oligomers - Alpha-synuclein amyloid oligomers and their pathogenic roles 9. An Evolutionary Affair - The connection between Gaucher disease and Parkinson's disease 10. Monkey Brains - Evolution of the human brain and the vulnerability of the substantia nigra 11. A Troublesome Subject - Exploring the possible connection between intelligence and Parkinson's and Alzheimer's diseases 12. Appendix - Alpha-synuclein in the gut, Crohn's disease, and the possible protective role of the synucleins in innate immune response 13. Circuitry - The discovery of neural pathways involved in Parkinson's disease and deep brain stimulation 14. Seeking a Magic Bullet - The search for new Parkinson's disease therapeutic agents 15. Journey's End - A recap of the chapters, the final conclusions, and new directions to explore
